Topical peptides for skin: separating real results from TikTok hype

What's this video probably claiming?

Based on the hashtags and caption, @evasachsdesigns is almost certainly walking viewers through a lineup of topical skincare peptides, likely comparing or recommending products containing argireline, Matrixyl 3000, Matrixyl Synthe'6, copper peptides (GHK-Cu), and NAD-adjacent ingredients. The framing "hacen el gran cambio" ("they make the big change") signals a transformation narrative, which is a common TikTok skincare format. Expect claims that these peptides visibly reduce wrinkles, firm skin, or mimic Botox effects, possibly with before-and-after visuals or product ranking. Brand tags like Skin Deva and Timeless Skin Care suggest this is product-focused, not a clinical discussion. That matters, because the difference between a 20-second TikTok and a 12-week randomized controlled trial is enormous, and viewers rarely get that context.

What does the science actually show?

The evidence base for topical peptides is real but frequently overstated. Argireline (acetyl hexapeptide-3) has some legitimate data: a small industry-funded trial by Blanes-Mira et al. (2002, International Journal of Cosmetic Science) showed a 17% reduction in wrinkle depth at 10% concentration after 30 days. Matrixyl (palmitoyl pentapeptide-4) showed increased collagen synthesis in vitro in work by Lintner and Peschard (2000, International Journal of Cosmetic Science), though in vitro results don't reliably translate to visible skin changes. GHK-Cu has a longer research history, with Pickart et al. describing its role in wound healing and collagen remodeling across multiple papers from the 1990s onward, but most strong data comes from wound care settings, not cosmetic aging. NAD precursors applied topically face a significant absorption problem that is rarely discussed on social media.

Where does the social media noise diverge from clinical reality?

Several gaps are worth flagging. First, concentration matters enormously. Argireline needs to be at or near 10% to reproduce study results, and most over-the-counter serums don't disclose their exact percentages. Second, skin penetration is the central unanswered question for nearly all of these peptides. GHK-Cu is a small tripeptide and may penetrate reasonably well, but larger peptides like those in Matrixyl Synthe'6 face a real barrier, literally, at the stratum corneum. A 2020 review by Gorouhi and Maibach in Skin Pharmacology and Physiology concluded that most topical peptides lack adequate human clinical trial data at cosmetically relevant concentrations. Third, the "Botox alternative" framing for argireline is persistently misleading. Botulinum toxin acts at the neuromuscular junction via a mechanism no topical peptide replicates.

What should you actually know?

If you're spending money on peptide serums, a few practical points matter more than any TikTok ranking. Formulation vehicle affects delivery more than the peptide name on the label. Products with penetration enhancers (certain lipid bases, liposomal delivery) may outperform a cheaper serum with a higher peptide percentage. Copper peptides can be destabilized by vitamin C in the same routine, so layering order matters. Independent verification of label claims is nearly nonexistent in this category, meaning a product can say "Matrixyl 3000" and contain a fraction of what was tested in studies. The honest summary: topical peptides are among the more science-adjacent cosmetic ingredients, they are not snake oil, but the gap between "some evidence" and "makes the big change" is wide enough to drive a clinical trial through.